COMPASS PATHWAYS PLC -

COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK

05 Jul 2021 06:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”

30 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression

28 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme

23 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences

08 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

03 Jun 2021 09:27:43 By Nasdaq GlobeNewswire

COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

13 May 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021

06 May 2021 08:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways announces pricing of public offering

29 Apr 2021 20:45:00 By Nasdaq GlobeNewswire

COMPASS Pathways launches proposed public offering

27 Apr 2021 17:22:18 By Nasdaq GlobeNewswire

New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder

15 Apr 2021 03:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference

09 Apr 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors

01 Apr 2021 07:01:00 By Nasdaq GlobeNewswire

COMPASS Pathways granted two US patents

23 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

09 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021

02 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to participate in Cowen's 41st Annual Health Care Conference

26 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists

09 Feb 2021 07:02:15 By Nasdaq GlobeNewswire

COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy

03 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference

28 Jan 2021 08:00:00 By Nasdaq GlobeNewswire